Near Fatal Stent Thrombosis in an Aneurysmatic RCX As First Manifestation of Heparin Induced Thrombocytopenia (HIT) Without Thrombocytopenia

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2022 Jan 1

PMID 34972517

Authors

Marc Zoller

Iskandar Atmowihardjo

Jeanette Huch

Ines Albrecht

Dirk Habedank

Affiliations

Soon will be listed here.

Abstract

Background: Thrombosis resulting from heparin-induced thrombocytopenia (HIT) occurs in about 2% of patients without a significant decrease in platelet counts. We report on such a near fatal thrombotic event caused by coronary intervention.

Case Presentation: A supposedly "completely healthy" 53-year-old patient was admitted to hospital with covered rupture of an aneurysm of the Aorta descendens. He was successfully operated on and underwent coronary angiography due to NSTEMI six days later. Immediately after intervention of a 90% RCX stenosis he developed ventricular flutter, was defibrillated, and re-angiography showed partial occlusion of the RCX stent. Lots of white thrombi could be retrieved by aspiration catheter and gave reason for a HIT without thrombocytopenia. The detection of platelet factor 4/heparin complex antibodies by immunoassay supported and the subsequent Heparin Induced Platelet Activation Assay proved this diagnosis.

Conclusions: The clinical event of an acute stent thrombosis should alarm the interventional team to the diagnosis of HIT even with a normal platelet count.

References

Selleng S, Malowsky B, Strobel U, Wessel A, Ittermann T, Wollert H . Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost. 2009; 8(1):30-6. DOI: 10.1111/j.1538-7836.2009.03626.x. View

Warkentin T, Kelton J . Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001; 344(17):1286-92. DOI: 10.1056/NEJM200104263441704. View

Cuker A, Arepally G, Crowther M, Rice L, Datko F, Hook K . The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010; 8(12):2642-50. DOI: 10.1111/j.1538-7836.2010.04059.x. View

Hermanns B, Janssens U, Handt S, Fuzesi L . Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome). Virchows Arch. 1998; 432(6):541-6. DOI: 10.1007/s004280050203. View

Warkentin T, Kelton J . A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996; 101(5):502-7. DOI: 10.1016/s0002-9343(96)00258-6. View

Mele M, Iacoviello M, Casavecchia G, Tricarico L, Brunetti N . Coronary thrombosis due to heparin-induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent. Clin Case Rep. 2021; 9(1):90-92. PMC: 7813037. DOI: 10.1002/ccr3.3448. View

Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin T, Eichler P . Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost. 2005; 94(1):132-5. DOI: 10.1160/TH04-12-0825. View

Warkentin T, Sheppard J, Horsewood P, Simpson P, Moore J, Kelton J . Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000; 96(5):1703-8. View

Oikonomou E, Repanas T, Papanastasiou C, Kokkinidis D, Miligkos M, Feher A . The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis. Thromb Res. 2016; 147:64-71. PMC: 5515466. DOI: 10.1016/j.thromres.2016.09.026. View

10.

Almeqdadi M, Aoun J, Carrozza J . Native coronary artery thrombosis in the setting of heparin-induced thrombocytopenia: a case report. Eur Heart J Case Rep. 2019; 2(4):yty138. PMC: 6426051. DOI: 10.1093/ehjcr/yty138. View

11.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K . Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost. 2007; 5(8):1666-73. DOI: 10.1111/j.1538-7836.2007.02617.x. View

12.

Greinacher A . CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia. N Engl J Med. 2015; 373(3):252-61. DOI: 10.1056/NEJMcp1411910. View

13.

Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G . Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016; 37(15):1208-16. DOI: 10.1093/eurheartj/ehv711. View

14.

Voudris V, Georgiadou P, Kalogris P, Kostelidou T, Karabinis A, Gerotziafas G . Missed Heparin-Induced Thrombocytopenia (HIT) Diagnosis in a Patient with Acute Stent Thrombosis. Am J Case Rep. 2019; 20:753-757. PMC: 6558115. DOI: 10.12659/AJCR.914988. View

15.

Okamoto H, Kume T, Fukuhara K, Kobayashi Y, Kawamura A, Goryo Y . Optical Coherence Tomography Findings in Early Stent Thrombosis by Heparin-Induced Thrombocytopenia. Int Heart J. 2016; 57(6):763-765. DOI: 10.1536/ihj.16-140. View

16.

Martel N, Lee J, Wells P . Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005; 106(8):2710-5. DOI: 10.1182/blood-2005-04-1546. View

17.

Rauova L, Zhai L, Kowalska M, Arepally G, Cines D, Poncz M . Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood. 2005; 107(6):2346-53. PMC: 1895727. DOI: 10.1182/blood-2005-08-3122. View

18.

Dai J, Madeeva D, Hayes V, Ahn H, Tutwiler V, Arepally G . Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia. Blood. 2018; 132(7):727-734. PMC: 6097133. DOI: 10.1182/blood-2018-02-830737. View

19.

Stoll F, Godde M, Leo A, Katus H, Muller O . Characterization of hospitalized cardiovascular patients with suspected heparin-induced thrombocytopenia. Clin Cardiol. 2018; 41(12):1521-1526. PMC: 6490101. DOI: 10.1002/clc.23061. View